impermissible, i.e. one has an obligation to refrain from such actions. Thus, the DDE has more force as a prohibitive principle than it has as a permissive principle [18] .
The DDE has important applications within medical ethics and clinical practice. One of the most common applications occurs in the abortion context, where its use is generally illustrated with a pair of contrasting cases: the hysterectomy and the craniotomy case. In the hysterectomy case, a pregnant woman has cancer of the uterus. A hysterectomy is required to save her life. The craniotomy case features an unborn child, whose head is lodged in the mother's birth canal. If the head is not dislodged, the mother will die. The head can only be dislodged through a craniotomy (crushing of the unborn child's head). Below, we present a commonly encountered approach to both cases. Alternative analyses are possible [14] . However, it is not our intention to endorse one or other approach. The discussion of these cases merely serves the purpose of illustrating the use of the DDE.
In both the craniotomy and hysterectomy case, the action under consideration has the same positive (the mother's life is saved) and negative (foetal death) effect. However, important differences between these cases become apparent once we apply the four conditions specified by the DDE:
(1) While performing a hysterectomy is in itself good or neutral, this does not hold true for the crushing of the unborn child' s skull. ( 2) The assessment of this condition is generally approached in one of two ways. Some (e.g. [19] ) believe that this condition rarely poses a problem when dealing with medical applications of the DDE as we may reasonably assume that medical professionals are not malevolent. Proponents of this view would, thus, argue that, in both the hysterectomy and the craniotomy case, only the good effect of preserving the mother's life is intended. Others, however, reject this baseline assumption of benevolent intention. Beauchamp and Childress [20] , for example, argue that one cannot but intend the bad effect of foetal death when performing a craniotomy. They reason that foetal death is a means (see condition (3) below) to save the pregnant woman's life. A means to one's end, they argue, is always intended. 4 (3) The removal of the uterus, not the death of the child, is what saves the mother's life in the hysterectomy case. Thus, the hysterectomy case satisfies the third condition. However, the craniotomy case does not. Since crushing the child's skull amounts to killing the baby, the good effect of preserving the mother's life is obtained through the bad effect.
(4) The hysterectomy case satisfies the proportionality requirement in that saving the mother's life constitutes a proportionate reason for allowing the child to die. Leaving aside the difficulty that killing could affect proportionality differently than allowing to die, we may suppose that the fourth condition is also met in the craniotomy case [18] .
The above analysis suggests that the hysterectomy case satisfies all four conditions of the DDE, whereas the craniotomy case does not. Thus, according to the generally held view, the hysterectomy is permissible, whereas the craniotomy is prohibited under the DDE.
The DDE also plays an influential role in the debate about end-of-life decisions. It has been invoked to justify the administration of pain-relieving medication to terminally ill patients in doses which would most probably hasten death, but where the death is an unintended side-effect of administering the medication. It distinguishes such actions from euthanasia and assisted suicide, in which the death of the patient is a means to reduce suffering [21] .
As mentioned earlier, the DDE is a controversial doctrine, and has been discussed extensively. The issues discussed range from the moral relevance of the intended/foresight distinction to the precise formulation of the principle [19] . However, these issues lie beyond the scope of this paper. We will only touch upon them insofar as they are relevant for the purpose of our paper.
DOUBLE EFFECT IN THE ETHICAL DEBATE ON BIOGERONTOLOGY
In this section, we first examine three passages from the debate on the merit of various approaches to tackling age-related diseases. Next, we argue that the authors of these passages engage in double effect reasoning, albeit only implicitly. Finally, we analyze the role which the argument appealing to the DDE is meant to fulfil. We claim that the argument, which we will refer to as the 'double effect argument', is appealed to by proponents of biogerontology in order to reach out to some of their (deontological) opponents: those who adhere to double effect reasoning.
A first excerpt is from the work of John Harris:
Remember that immortality is not unconnected with preventing or curing a whole range of serious diseases. It is one thing to ask whether we should make people immortal and answer in the negative; quite another to ask whether we should make people immune to heart disease, cancer, dementia, and many other diseases and decide that we shouldn't, because a "side effect" of the treatment would be an increase in life expectancy. We are then, unlikely ever to face the question, Should we make people immortal: Yes or no? We may rather be called upon to decide whether we should treat this disease when we know an effective treatment will extend lifespan. It might then be appropriate to think of immortality as the, possibly unwanted, side effect of treating or preventing a whole range of diseases. Could we really say to people, "You must die at the age of 30 or 40 or 50, because the only way we can cure you is to make you immortal or let you live to be 200 or 300"? [22, p. 10] An implicit appeal to double effect is also present in the work of David Gems:
Decelerating human ageing would have two outcomes that are very different in ethical terms. The above passages exhibit a common structure in that they feature an action with a good and a bad effect. In each case, the identified bad effect is a (radically) increased maximum lifespan. Concerning the action at play, it is clear that both Gems and de Grey are discussing the 'strong' approach to tackling age-related diseases, i.e. the act of intervening in the ageing process itself. After all, de Grey speaks of combating "ageing itself". Gems, on the other hand, refers to "decelerating human ageing", a recognized instance of intervening in ageing. In Harris' case, the reference to "treating or preventing a whole range of diseases" initially suggests that he is discussing the 'weak' approach. However, on closer inspection, he appears to be using the latter phrase as a misnomer for the 'strong' approach.
Harris speaks of the bad effect in terms of "immortality". As noted in the introduction, an increase in maximum lifespan of this magnitude can only be achieved through the 'strong' approach. Harris' reference to the good effect as "immunity to age-related diseases" further supports our claim that he is indeed addressing interventions in the ageing process. Such immunity after all, is only achievable through the 'strong approach'. Let us now turn to the good effect identified by Gems and de Grey.
They respectively speak of "greatly reducing the frequency of ageing related illness at any given age" and "the prevention of the suffering associated with old age". Despite the differences in the terminology employed by these authors in reference to the good effect, there appears to be a common denominator. All of the identified good effects amount -as these authors themselves acknowledge -to the (indefinite) postponement of age-related diseases. The common structure of the above passages is illustrated in Fig.1. [ Fig. 1 common structure of the passages]
Establishing the presence of the DDE
In featuring an action with a good and a bad effect, the quoted passages incorporate a basic characteristic of double effect reasoning. However, more is needed in order to establish the presence of the DDE. The key characteristic of double effect reasoning is the intended/unintended distinction.
Below we argue that Gems, de Grey, and Harris appeal to this distinction, albeit implicitly.
There is a broad consensus among proponents of biogerontology that the field's goal or objective consists in increasing the human healthspan (see, for example, [25, 26] ). Terms such as 'goal' and 'objective' undeniably denote intention. As they are ardent proponents of biogerontology, Gems, de Grey, and Harris very likely endorse the claim that interventions in ageing are intended to increase the healthspan. The good effect which these authors refer to in the quoted passages amounts precisely to an increase in the healthspan. Thus, when Gems, de Grey and Harris mention this good effect, we may reasonably interpret them as saying that this is the intended effect of intervening in ageing. The fact that they juxtapose the good effect with an unwanted bad effect further strengthens our claim that the good effect is what they consider to be the intended effect.
We have established the presence of the first component of the intended/unintended distinction, i.e. the fact that the good effect is intended. Are there any grounds to interpret the bad effect as referring to an unintended effect? As suggested above, the term 'unwanted', which is used in reference to the bad effect, could be considered as denoting a lack of intention. However, there is another, much more sound basis for inferring the presence of the intended/unintended distinction. According to Cavanaugh
[27], the latter distinction can interchangeably be referred to as the 'intended/side effect' distinction.
Gems, Harris, and de Grey each refer to the bad effect in terms of a side effect. This, combined with the already established presence of a good, intended effect, implies that the quoted passages contain the characteristic distinction of the DDE. Advocates of biogerontology face strongest opposition from those whose beliefs are grounded in deontological arguments. Many deontologists consider the act of intervening in the ageing process impermissible on the grounds that it brings about an extended maximum lifespan -a state of affairs which they deem intrinsically bad [28] . 5 Most proponents of intervening in the human ageing process do not themselves adhere to the DDE. Thus, in appealing to this deontological model, the latter seemingly attempt to win over their aforementioned opponents. In sum, advocates of biogerontology hope to convince their deontological opponents of the permissibility of intervening in ageing by framing this act within the DDE. In light of its rhetorical purpose, how exactly should we understand the double effect argument? We should interpret those appealing to this argument as saying the following: "Deontologists claim that an extended maximum lifespan is a bad state of affairs. Anyone would agree that there is much value in having age-related diseases postponed. The latter can be achieved by intervening in the ageing process. Admittedly, such interventions would also bring about an extended maximum lifespan, thereby breaching a deontological prohibition. Does this imply that deontologists necessarily ought to condemn the act of intervening in the ageing process? No. Once we frame this act within the DDE, it becomes permissible. After all, the act of intervening in ageing is morally neutral. The extended maximum lifespan (the bad effect) is an unintended effect of intervening in ageing. The intention is merely to bring about the good effect, i.e. the postponement of the onset of age-related diseases. In addition, the bad effect is not a means to the good effect. Finally, there is a proportionately grave reason for permitting the bad effect."
As noted above, many deontologists consider an extended maximum lifespan a bad state of affairs.
When defending their position on this matter, deontologists differ somewhat in the aspects which they emphasize [29] .
A first group appeals to human nature (see, for example, [30, 31] ). The good is that which conforms to human nature, whereas the bad is that which represents a perversion of the latter. 
TESTING THE SOUNDNESS OF THE 'DOUBLE EFFECT ARGUMENT'
The question remains whether those who appeal to the 'double effect argument' would succeed in winning over their deontological opponents. The argument will only be successful if these deontologists view the act of intervening in ageing as satisfying each of the 4 conditions of the DDE.
Below, we reconstruct the way in which deontological opponents of biogerontology are likely to assess interventions in ageing against the standard of the DDE.
Condition 1: is the action in itself morally good or neutral?
Is intervening in the ageing process a good or at least morally neutral action, independent of its consequences?
Some deontologists will a priori reject interventions in the ageing process on the grounds that ageing is not a disease; it is a normal process that should not be intervened in. In short, on this view, interventions in the ageing process are unacceptable as they constitute 'enhancement', not 'therapy'
[28].
Deontologists, such as Kass, who are primarily concerned with preserving human nature may accept natural interventions in the ageing process. We have described the action to be justified as 'intervening in the ageing process', but there are different ways of doing so. For example, one could do this by administering a drug that switches on a gene associated with longevity, or one could intervene in the ageing process using caloric restriction. Whether a deontologist concerned with preserving human nature regards a certain intervention in the ageing process as good or neutral will depend on how she understands 'unnatural'. If 'unnatural' is understood as all that is human-made, then she may accept caloric restriction but reject all medical-technical interventions. However, given the radical implications of this view (i.e. the need to renounce medicine altogether), few deontologists would advocate this interpretation of 'unnatural'. Another, for deontologists more plausible view, equates 'unnatural' with a significant deviation from 'normal' processes; in this case from 'normal' bodily functioning. Caloric restriction (mimetics) could then be accepted because it respects the normal bodily processes, whereas gene therapy would be rejected. When we deprive the body of food, as is the case in caloric restriction, we merely trigger a programmed reaction in the body. Obviously, caloric restriction mimetics would trigger the very same reaction. However, in the case of gene therapy, we are reprogramming the body's normal reaction, rather than addressing its latent potential.
'Life cycle traditionalists' will most probably reach the same verdict as those concerned with preserving human nature. After all, as noted above, they too draw upon the concept of human nature, albeit implicitly.
One may object to this analysis by pointing out that one can always redescribe the action to be justified in such a way that it is neutral or good, and, thus, always meets the first condition. This is the 're-description problem' first mentioned by Philippa Foot [35] . The problem is that the first condition separates the action from its effects or consequences. It stipulates that the action in itself has to be good or neutral, independent of its effects or consequences. But if we have to consider the action independent of its effects, we can always describe it in a neutral way. For example, in the infamous craniotomy case, the action could be described as killing the foetus, but also as reducing the size of the foetus's skull. Likewise, one could describe the action 'intervening in the ageing process through genetic manipulation' as 'administering a drug' with one side-effect that a gene associated with the ageing process is switched off and another side-effect that an extended maximum lifespan is obtained.
The action to be justified might then be considered good or neutral by deontologists. One proposed solution to this problem is to implement a criterion of closeness, linking intended actions to their closely related side-effects so that they are inseparable from the action. Since the drug works by switching off a gene that plays a crucial role in the ageing process, it surely is more plausible to describe the action as 'a genetic intervention in the ageing process'. It is plausible that one cannot separate the means used (i.e. the drug) from the mechanism (i.e. switching off a gene) through which the means works.
So depending on the mechanism involved, some deontologists will not consider the action to be justified as good or neutral. If condition 1 is not met, then the argument appealed to by defenders of biogerontology to convince some of their opponents will not hold. However, for those deontologists who regard the action as neutral or good, the argument could still work if the other conditions are met.
Condition 2: is the bad effect unintended?
Does the agent only intend the good effect? Is the bad effect -the extended maximum lifespanmerely a foreseen but unintended side-effect? Before answering these questions, we would like to address a common misconception. The DDE is sometimes interpreted as making the permissibility of an action turn on the actual intentions of a particular agent (see, for example, [36] [37] [38] ). According to this interpretation, the act is permissible when the individual performing it merely intends the good effect. Conversely, the act becomes impermissible when conducted by an individual who intends the bad effect. FitzPatrick [39] has convincingly refuted this interpretation of the DDE. According to FitzPatrick, the requirement which needs to be met in order for condition 2 to be satisfied, is situated on an abstract, theoretical level -as opposed to the practical level of the particular individual and her intentions. All that is required for condition 2 to be met, is that it is theoretically conceivable that one acts without intending the bad effect. Thus, where a particular agent acts with malevolent intentions, condition 2 could still be met. What matters for an act to be permissible is that one could act without intending the bad effect. Conversely, condition 2 is violated when, whatever the circumstances considered, one cannot but act with malevolent intentions.
Controversy exists about how to determine whether an effect of an action is an intended effect [40]. A commonly applied test to account for the distinction between intended and merely foreseen effects is the counterfactual test [41]
. This test asks whether an agent would still do the act if she thought that the bad effect would not occur. If the non-occurrence of the bad effect would deter the agent from performing the relevant action, we may conclude that she intends the bad effect. In light of our abovementioned remark, the agent referred to in the counterfactual test should be interpreted as an agent 'in the abstract', rather than a particular agent. Applied to the question at hand, the counterfactual test goes as follows: can a doctor who intervenes in the ageing process reasonably say that if she could do so without obtaining an extended maximum lifespan, she would? We believe that she could. Suppose that a patient has a genetic predisposition for developing an age-related disease, or a set of age-related diseases. Furthermore, suppose that a doctor knew that, if she intervened in the patient's ageing process, the onset of the age-related disease(s) would be postponed, but the patient's life would not be extended beyond the maximum lifespan (say, because her patient is a Death Row inmate). It is plausible that the doctor would still perform the action -intervening in the ageing process -if this is the most efficient, or the only way of postponing the (set of) age-related disease(s).
Does our Death Row scenario provide sufficient grounds for concluding that condition 2 is met?
Recall that condition 2 is violated when, whatever the circumstances considered, an agent intervening in the ageing process necessarily intends the bad effect. Conversely, then, condition 2 is met when one can conceive of at least one case -set of circumstances -under which one could intervene in the ageing process without intending the bad effect. Our Death Row scenario provides precisely such a counterexample.
Condition 3: is the bad effect used as a means to the good effect?
Is the extended maximum lifespan a means to the (indefinite) postponement of age-related diseases?
The general idea behind this condition is that a harm that might permissibly be brought about as a side-effect in promoting a good end could not be permissibly brought about as a means to the same good end.
There are two ways of approaching the assessment of this third condition, depending on how one views its relationship to the second condition. While some consider both conditions as interchangeable, others regard them as separate conditions which cannot be reduced to one another.
Below, we determine, from each of these perspectives, whether the third condition is satisfied.
Marquis [40]
, who advocates the interrelatedness between the second and third condition, argues as follows:
In general, if Mangan's condition (3) is violated, then the good effect is produced by means of the evil effect. If we grant the doctrine that he who intends the end also intends the means, then the evil effect is intended. And if the evil effect is intended, then condition (2) is violated.
Hence, if condition (2) is satisfied, then so is condition (3). [40, p. 520]
Following this line of reasoning 6 , we can simply deduce whether or not the third condition is met from our findings regarding the second condition. In our analysis of condition 2, we have established, using the counterfactual test, that the bad effect, i.e. the extended maximum lifespan, is unintended.
Therefore, since one's means are always intended, the bad effect cannot be a means to the good effect (i.e. the (indefinite) postponement of age-related diseases). In sum, the third condition is met on this view.
Is the third condition met from the perspective of those who repudiate its interconnectedness with the second condition? On this view, both conditions differ clearly in that the second asks whether the bad effect is intended as an end, whereas the third inquires whether it is intended as a means. How does 'intending as an end' differ from 'intending as a means'? It has been argued that if an agent believes that her action has a certain direct effect and this belief is the rationale behind her action, the agent intends this effect as an end [19] . For example, if I write a book because I believe it will make me famous, then I intend becoming famous as an end. The concept of 'intending as a means' amounts to the following: "If an agent believes that φ -ing [where φ stands for some verb of action] has a certain effect (E 1 ) and believes that E 1 is related (causally or otherwise) to another effect (E 2 ) and the latter belief is a reason for her to φ, then the agent intends E 1 as a means to E 2 and she intends E 2 as an end" [19, p. 468-469] . Suppose that a murderer turns herself in. She believes that this will lead to her being executed, which in turn will relieve her of the remorse that haunts her. The murderer, then, intends her being executed as a means to ending her psychological suffering, which she intends as an end.
On this view, the fact that the second condition is satisfied 'merely' tells us that the bad effect (the extended maximum lifespan) is unintended as an end. This, in itself, does not give anything away concerning the third condition as the bad effect may very well be unintended as an end, yet intended as a means. We, therefore, need a way of independently assessing whether or not the bad effect constitutes a means to the good effect. Several tests have been proposed. Below, we apply two widely applied tests to the case at hand. We show that, on both tests, the bad effect (extended maximum lifespan) is not a means to the good effect.
A first test is the 'inevitable connection test' [40]. According to this test, if the action is inevitably
connected to the bad effect, we may conclude that the latter is used as a means to the good effect. The idea behind this test is that the presence of such an inevitable connection implies that the action and the bad effect merge into one another. Given that the action is necessarily a means to the good effect, the bad effect must, then, also be so. Note that the inevitable connection test is, for example, implicitly relied upon in the analysis of the craniotomy case. Here, crushing the foetus' skull (the action) is considered identical to the foetus being killed (the bad effect). For this reason, the foetus' death is taken to be a means to the good effect.
Is the action of intervening in the ageing process inevitably connected to the extended maximum lifespan ? It seems that it is not. In being (temporarily) relieved from ageing and its concomitants, one is not in any way protected against other potential causes of death, such as fatal non-ageing-related diseases, suicide, murder, etc. One may not reach the current maximum lifespan, despite having undergone treatment to decelerate or arrest ageing. Thus, according to the inevitable connection test, the extended maximum lifespan does not constitute a means to the good effect.
A second test simply consists in applying another definition of 'means', one which better approximates the common-sense understanding of the concept. Dan Brock [42] , for example, offers such a definition: "The means are what an agent does because he believes them to be causally necessary or sufficient on the particular causal path taken to achieve his end" [42, p. 532] . The case for a prohibition against euthanasia and physician-assisted suicide under the DDE, for example, is built on an implicit use of this 'causal criterion'. The reason why a doctor performs such actions is the belief Consider a scenario in which a significant part of the population requests an intervention in their ageing processes. Here, as is the case with the 'small scale scenario', omitting to bring about the good effect amounts to letting people die. The number of people that would die is much greater in the 'large scale scenario' than it is in the 'small scale scenario'. At first sight, then, the case for proportionality appears still stronger in the former scenario, relative to the latter. Nevertheless, a closer look at the bad effect in both scenarios compels us to revise this initial assessment. In the 'small scale scenario' the bad effect 'merely' amounts to a breach of the prohibition on an extended maximum lifespan.
However, in the 'large scale scenario', the 'evil' inherent in the bad effect may go well beyond a breach of this single prohibition.
Many deontologists (see for example [45] ) fear that there is a serious threat of overpopulation when Deontologists with these concerns could argue that in breaching the prohibition on an extended maximum lifespan, the medical community may also be breaching its duty not to inflict harm upon people. For these deontologists, the harm inflicted as a result of providing interventions in the ageing process will likely even amount to letting people die. After all, they view overpopulation as creating a situation in which people are inevitably deprived of basic needs for continued life. Ultimately then, they could reformulate the bad effect in terms of letting people die. Recall that the non-occurrence of the good effect also amounts to letting people die. From the perspective of the above deontologists, the proportionality condition will probably not be met in the 'large scale scenario'. First, in bringing about the bad effect we are breaching two prohibitions; we are both obtaining an extended maximum lifespan and letting people die. In refraining from intervening in the ageing process, on the other hand, we are merely breaching one prohibition. Second, population-related global warming and other harms attached to overpopulation may affect people worldwide. As Billings [47] argues, a harm affecting society generally carries more weight than one affecting merely an individual. Therefore, the globally felt effect of people dying likely constitutes too great an evil to justify interventions in the ageing process. The latter holds true, regardless of the magnitude of the good effect. 10 10 One might object that this verdict of non-proportionality is based on a problematic assumption, i.e. the conviction that overpopulation and its detrimental effects will occur. However, whether or not we will actually be confronted with overpopulation and its detrimental effects is irrelevant. We are merely interested here in
One might object that the reformulation of the bad effect in terms of harm to others is only obtained through an 'aggregative view', i.e. through considering the numerous interventions in the ageing process by many doctors together. More specifically, one might argue that on a 'piecemeal view', where every single intervention in the ageing process is considered separately, the bad effect merely amounts to one person obtaining an extended lifespan. Is the 'aggregative view' then the correct one to take? We think it is. Adopting the 'piecemeal view' in a context where one's action impacts not only upon the patient, but also on others, seems wrong. The 'piecemeal view' is oblivious to the potential effects of a large scale use of anti-ageing interventions on society at large. Parfit's 'Harmless Torturers' case [48] supports the use of the aggregative view in the 'large scale scenario'. In this hypothetical scenario, a thousand people each push a button that turns the dial of a torture machine one click. Whereas a single click causes imperceptible pain to the victim, the pain associated with a thousand clicks is excruciating. According to the 'piecemeal view', none of these torturers ever acts wrongly given that a single turn of the dial merely causes imperceptible pain. This conclusion is absurd. What matters is that, taken together, these torturers' acts inflict severe pain on the victim.
Likewise, taken in aggregate, each doctor's intervention in the ageing process harms society at large.
CONCLUSION
Proponents and opponents of biogerontology have generally criticized each other's arguments from within their own moral frameworks. Recently, however, we observe a departure from this trend, with advocates of biogerontology seemingly appealing to arguments tailored to their opponents' normative theory. We have here examined one such argument, the 'double effect argument'. Although this argument deserves credit for breaking with a long-lasting tendency, it stands little chance of winning over its target audience, i.e. deontologists who consider the act of intervening in the ageing process impermissible. Our analysis suggests that deontologists may plausibly deem such interventions impermissible under the DDE. While it is plausible that interventions in the ageing process satisfy the second (the bad effect is unintended) and third (the bad effect is not a means to the good effect)
conditions of the DDE, the first (the act is good or neutral) and fourth (the good effect outweighs the bad effect) conditions are problematic. Many deontologists may find the act of intervening in the ageing process not neutral or good in itself. Some may condemn it outright on the grounds that ageing is a normal process that should not be intervened in. Others may deem such acts morally good or neutral on condition that they constitute natural interventions in the ageing process. In any case, deontologists could plausibly argue that neither unnatural nor natural interventions satisfy the proportionality condition as both types of intervention involve an unacceptable trade-off between saving the lives of some (patients who undergo the interventions) and letting others die (those who reconstructing the way in which deontological opponents of biogerontology may assess interventions in ageing against the standard of the DDE. From this perspective, all that matters is that there are deontologists who fear overpopulation and who, on this basis, would reject the idea of the proportionality condition being met.
suffer the consequences of large scale interventions in the ageing process). The assessment of the proportionality condition brings to light an important difference between the case discussed here and classical medical applications of the DDE. In these classical cases, the bad effect of the agent's act merely affects the patient (or the foetus, in cases where unborn life is at stake), never society at large. Therefore, the scale on which such 'classical' acts are executed does not impact upon the outcome of the proportionality assessment.
In this paper, we have tried to 'reconstruct' the way in which deontological opponents of biogerontology may assess interventions in ageing against the standard of the DDE. One might contest the soundness of our reconstruction, arguing that interventions in ageing are permissible under the DDE. However, even if the latter could be convincingly argued, it may not further the cause much of those appealing to the 'double effect argument'. Presumably, the whole point of winning over deontological opponents consists in securing the much needed (public) funding for biogerontological research. Therefore, an argument is needed which provides these opponents with an incentive to act in a way which enables the development of interventions in ageing. However, the incentive provided by the DDE is not as strong as it could be, given that the DDE merely confers a permission to act, not an obligation.
